We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
-3.43%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$1.18M
AUM Growth
-$1.05B
Cap. Flow
-$403M
Cap. Flow %
-34,025.24%
Top 10 Hldgs %
51.44%
Holding
164
New
55
Increased
4
Reduced
8
Closed
25

Top Buys

Rank Stock Value
1
BGC icon
BGC Group
BGC
+$27.8M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$16.1M
3
JXN icon
Jackson Financial
JXN
+$12M
4
AAMI
Acadian Asset Management
AAMI
+$7.05M
5
WQGA.U
World Quantum Growth Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant to acquire one Class A ordinary share
WQGA.U
+$5M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$115M
2
WORK
Slack Technologies, Inc.
WORK
+$86.8M
3
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$73.7M
4
BABA icon
Alibaba
BABA
+$72.9M
5
WTW icon
Willis Towers Watson
WTW
+$53.2M

Sector Composition

Rank Sector Weight
1 Financials 11.54%
2 Consumer Discretionary 7.69%
3 Healthcare 5.6%
4 Industrials 5.14%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JWSM.WS
76
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$115 0.01%
100,000
– –
ZURAW
77
DELISTED
Zura Bio Limited Warrants
ZURAW
$113 0.01%
+187,500
New +$109K
INDIW
78
DELISTED
indie Semiconductor, Inc. Warrant
INDIW
$107 0.01%
30,338
-160,486
-84% -$375K
IPOD.WS
79
DELISTED
Social Capital Hedosophia Holdings Corp. IV Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOD.WS
$88 0.01%
50,000
– –
LCAAW
80
DELISTED
L Catterton Asia Acquisition Corp Warrant
LCAAW
$87 0.01%
116,666
– –
AUS.WS
81
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$85 0.01%
50,000
– –
SPKBW
82
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$81 0.01%
75,000
– –
HERAW
83
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$77 0.01%
75,000
– –
HCNEW
84
DELISTED
Jaws Hurricane Acquisition Corp. Warrant
HCNEW
$72 0.01%
+62,500
New +$69.8K
EOCW.WS
85
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$69 0.01%
+62,500
New +$66.8K
AAC.WS
86
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$68 0.01%
80,000
– –
ASZ.WS
87
DELISTED
Austerlitz Acquisition Corporation II Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
ASZ.WS
$66 0.01%
62,500
– –
OACB.WS
88
DELISTED
Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share
OACB.WS
$56 ﹤0.01%
62,500
– –
DCRNW
89
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$56 ﹤0.01%
45,455
– –
SPAQ.WS
90
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$55 ﹤0.01%
50,000
– –
PV.WS
91
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$53 ﹤0.01%
62,500
– –
HAACW
92
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$52 ﹤0.01%
50,000
– –
SSAAW
93
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$47 ﹤0.01%
66,666
– –
TBCPW
94
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$45 ﹤0.01%
60,000
– –
WPCA.WS
95
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$45 ﹤0.01%
40,000
– –
WPCB.WS
96
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$37 ﹤0.01%
40,000
– –
OHPAW
97
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$35 ﹤0.01%
55,000
– –
ENJYW
98
DELISTED
Enjoy Technology, Inc. Warrant
ENJYW
$32 ﹤0.01%
22,866
+2,992
+15% +$3.03K
KAHC.WS
99
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$30 ﹤0.01%
31,250
– –
SLAMW
100
DELISTED
Slam Corp. warrant
SLAMW
$28 ﹤0.01%
31,250
– –
2 3
4
5 6

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return

Boussard & Gavaudan Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Boussard & Gavaudan Investment Management held 164 positions worth $1.18M, down 100% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $403M in Q3 2021, closing 25 positions and reducing 8 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $115M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in BGC Group worth $27.3K.

  • Boussard & Gavaudan Investment Management's largest Q3 2021 buy was BGC Group: 5,236,279 shares worth $27.3K.
  • Boussard & Gavaudan Investment Management added most to Octave Specialty Group in Q3 2021, an estimated $3.11M increase.
  • Boussard & Gavaudan Investment Management's biggest Q3 2021 reduction was Alibaba, cutting an estimated $72.9M.
  • Boussard & Gavaudan Investment Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $115M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 51% of its $1.18M portfolio in Q3 2021.
  • Boussard & Gavaudan Investment Management opened 55 new positions and closed 25 in Q3 2021.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $1.18M.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q3 2021, filed 8 Nov 2021.